Specifically, we hypothesized that the concentration of circulating glial fibrillary acidic protein (GFAP), a marker of astrocyte damage,12 would be elevated in patients with WD with neurological manifestations (WD‐NM). This evidence concerns the gene GFAP and nemaline myopathy.